Learn from your peers and industry experts in sourcing, procurement, and supply management on key issues to help drive your business forward. For speakers and topics, click on the session details below.
C-suite, senior and mid-level executives in sourcing, procurement, and supply management of direct materials used in pharmaceutical and biopharmaceutical development and manufacturing, packaging, and the related supply chain.
Please note: To deliver targeted insight and create a comfortable environment for attendees, DCAT and its planning committees respectfully require that Buyers’ Track attendees’ primary job functions are sourcing, procurement & supply management. DCAT reserves the right to reassign registrants to the appropriate track.
Heading to the Hyatt the evening before?
Join us the night before the forums on June 25th from 8:00-10:00PM for our Pre-Program Welcome & Networking Reception at the Glass Woods Tavern on the first floor of the Hyatt Regency Hotel!
Speaker: Nuria Ramirez, Procurement Program Lead and Senior Director, Janssen Supply Chain Procurement, Johnson & Johnson
Speaker: Andreia Racioppi, Executive Director, Global Strategic Accounts, GE Healthcare Life Sciences, Roberto Silveira, PhD, Vice President, Biotechnology Aseptic Sciences Group, Pfizer
Speaker: Ben Aylor, Senior Partner and Managing Director, The Boston Consulting Group
Blockchain is an emerging technology to enable improved supply-chain governance. So what is all the buzz about blockchain, and is it a valuable tool for sourcing and procurement? How is it now being applied in sourcing and procurement in the pharmaceutical industry and outside the industry? Learn to see if blockchain should be on your company’s radar.
Featuring co-presentations of pharmaceutical companies and suppliers, this session offers candid perspectives on real-world challenges that arise in a campaign and how partners resolved those issues, including:
Cost-Competitive Manufacturing through Collaboration and Relationship Management
Merck’s antibiotic portfolio requires compliant, cost-competitive manufacturing of beta-lactam intermediates that are hard to source due to stringent segregation requirements. Merck looked early on, beyond loss of exclusivity, to create a cost-competitive manufacturing center of excellence that also provided regulatory, quality, and environmental, health, and safety (EHS) compliance. Merck and Asymchem will look back and share the details of this journey, from reconfiguring a CMO site into a beta-lactam facility and the initial challenges to the evolution of collaboration and relationship management that expanded this initial opportunity into a future collaboration.
Partnering for Security of Supply
The success of a business’s global supply chain depends on managing and mitigating risks and working with partners to achieve security of supply. Teva Pharmaceuticals and Amcor will provide lessons learned on how they resolved a potential disruption in supply of packaging materials using an advanced sourcing approach with upstream suppliers. They will discuss how they addressed short-and longer-term supply needs, enabled qualification of alternative product choices, and managed inventory and cost.
Launching Innovative Oncology Drugs Through External Collaboration: Specialized Technologies and Accelerated Timelines
Oncology is the largest therapeutic market sector in the global pharmaceutical industry, and it presents opportunities for promising drug candidates and commercial products. Those opportunities, however, also can come with unique challenges in drug-substance development and manufacturing, especially for a biotech company that relies on contract development and manufacturing organizations (CDMO). TESARO, Inc., and WuXi STA will provide their experience in developing a small-molecule oncology drug and the approaches they took for a project requiring specialized technologies in potency manufacturing under rapid timelines from development to commercial launch.
In an era when chief procurement officers (CPOs) are trying to unlock the next gear of productivity, how can Big Data capabilities be used to transform procurement and sourcing practices? Gain first-hand insight from a CPO with experience gained from Fortune 500 companies Biogen, Kraft, and Kellogg’s on how Big Data tools and a new methodology, “constraintless bidding,” can be used to drive savings and value. Learn how a robust Big Data analytics strategy is a gateway to transition “analog” procurement practices into “digital” practices by enabling the application of robotic process automation (RPA), machine learning, natural language processing, and artificial intelligence.
Speaker: Wendell P. Weeks, Chairman and CEO, Corning Incorporated
What does it take to bring supplier-enabled innovation to fruition? Learn of the key success factors to build truly collaborative partnerships and to execute a winning strategy.
Wendell P. Weeks, Chairman and Chief Executive Officer (CEO) of Corning Incorporated, will share his insights and lessons learned from his 35-year career with Corning with examples from the company’s work with partners such as Apple Inc., Samsung Electronics Co., Ford Motor Company, Verizon, Sharp Corporation and most recently, Pfizer, Inc. and Merck & Co., Inc.
In 2017, Corning announced a planned investment of $4 billion with the introduction of a new product, Corning Valor Glass, for parenteral drug packaging that was the outgrowth of its partnership with Merck & Co., Inc. and Pfizer, Inc., which provided insights on pharmaceutical formulation and manufacturing processes.
As a result of the companies’ common goal to improve glass quality and promising results from initial testing, Corning is making an initial investment of $500 million as the first part of planned investment of $4 billion. Mr. Weeks will discuss the structure and governance of the collaboration and how the companies partnered in new product development, including addressing ways to lower systems costs and improve manufacturing efficiency, in order to bring the product to market.
Click here for full bio.
Procurement Program Lead and Senior Director, Janssen Supply Chain Procurement
Johnson & Johnson
Nuria Ramirez is Procurement Program Lead and Senior Director, Janssen Supply Chain Procurement, Johnson & Johnson (J&J), where she is responsible for leading the strategic procurement program and implementation of key strategic projects for Janssen Supply Chain.
She has 30 years of experience within the Johnson & Johnson Family of Companies with increasingly responsible positions in quality assurance, manufacturing, process excellence, plant management, and procurement in the pharmaceutical and consumer sectors of J&J in the US and Puerto Rico. Throughout her tenure, she has achieved multiple accomplishments, and most recently implemented a Supplier Partnership Program focused in partnering and collaborating with suppliers to enhance value-chain performance and reliability of supply, achieve total cost reduction, and deliver long-term mutual benefits for both the company and suppliers.
Ms. Ramirez is a J&J certified Lean Black Belt and has made significant contributions to the Lean deployment for J&J and the pharmaceutical sector. She is a member of the Global Procurement Women Leadership Initiative and is actively mentoring future women leaders. She is a board member for Alianza para un Puerto Rico sin Drogas and serves as a volunteer for PRIOR (Puerto Rico Institute of Robotics). She holds a bachelor’s of science in chemistry from Interamerican University of Puerto Rico.
Executive Director, Global Strategic Accounts
GE Healthcare Life Sciences
Roberto Silveira, PhD
Vice President, Biotechology Aseptic Sciences Group
Roberto Silveira, PhD, is Vice President, Biotechology Aseptic Sciences Group, Pfizer, where he is responsible for the manufacturing science and technology for biological and sterile injectable products from the drug substance to the final formulation and filling, a role he has served since 2009. Since joining Pfizer in 1989, Dr. Silveira has held various leadership roles, including Senior Director of bioprocess support for biological drug substances, new product introductions, and marketed products and Drug Substance Manager for Asia/South America.
Senior Partner and Managing Director
The Boston Consulting Group
Ben Aylor is a Senior Partner and Managing Director at The Boston Consulting Group (BCG). In his 20 years of consulting experience, he has focused on topics in biopharmaceutical manufacturing, including network design, organizational transformation, post-merger integration, and digital supply chain. Mr. Aylor is BCG’s global leader in biopharmaceutical network strategy and recently has helped both Big Pharma and mid-sized pharma clients develop capabilities and capture value using advanced analytics and digital techniques.
James Gage, PhD
Chief Scientific Officer
James Gage, PhD, is the Head of Research and Development and Chief Scientific Officer for Asymchem, where he manages implementation of commercial processes in Asymchem’s manufacturing facilities and leads efforts to expand the company’s capabilities through development and application of new technology.
He has 27 years of experience in process chemistry and other aspects of pharmaceutical chemistry, manufacturing and controls (CMC). Prior to joining Asymchem in early 2006, Dr. Gage worked for Pfizer and Upjohn for over 14 years. He earned a PhD in chemistry with Professor David Evans at Harvard University.
Senior Vice President and Chief Procurement Officer
Walter Charles is the Senior Vice President and Chief Procurement Officer (CPO) at Allergan, where his global procurement teams support the purchase of billions of dollars a year of products and services supporting research & development, manufacturing, marketing, legal, capital, information technology, plant operations, travel, and general and administrative services. Prior to joining Allergan, he held CPO roles at companies such as Biogen, Kraft Foods, Kellogg’s, Johnson & Johnson Consumer Supply Chain, and Cordis (one of Johnson & Johnson’s former medical devices companies). As such, he has the unique perspective of serving on supply-chain leadership teams and leading procurement transformations across multiple industries, including biotechnology, consumer packaged goods, pharmaceutical, and medical devices.
Tangqing Li, PhD
Executive Director of Project Management
STA Pharmaceutical, a WuXi AppTec company
Tangqing Li is Executive Director of Project Management, STA Pharmaceutical, a WuXi AppTec company, where he heads US-based project management. He has extensive knowledge and experience in both early- and late-phase drug development, including process validations, program management, and regulatory filings. He earned his PhD in organic chemistry at Rice University and his bachelor’s of science in chemistry at Peking University.
Prashant S. Savle, PhD
Director, Commercialization Projects, Global Procurement
Merck & Co., Inc.
Prashant S. Savle, PhD, is Director, Commercialization Projects, Global Procurement, Merck & Co., Inc., where his responsibilities include commercialization of drug substances and non-sterile and sterile drug-product formulations.
He has over 20 years of technical, business, and program-management experience, including global experience in technology development and scale-up, research and development, and clinical active pharmaceutical ingredient, sourcing, process validation, and commercial contract management. He brings a unique blend of experience from buyer-side sourcing and as a project manager with large contract manufacturing organizations, such as Rhodia ChiRex, Avecia Biotechnology, Inc. and Sigma-Aldrich Fine Chemicals.
Dr. Savle has supported drug-substance manufacturing projects spanning small molecules, antibiotics, bioconjugates, peptides, and oligonucleotides and has been a part of launch teams that have obtained 20 new drug approvals to date. He has a PhD in organic chemistry from the University of Cambridge, UK.
Daniel J. Hoey is Senior Vice President, Global Supply Chain, Global Operations, Teva Pharmaceuticals, where he has responsibility for ensuring the highest levels of customer service for a fully integrated global manufacturing and supply-chain organization that supports Teva’s global operations network, which delivers patient-centric healthcare solutions to millions of patients in more than 100 markets.
He has nearly 30 years of experience in the global pharmaceutical industry as a senior leader specializing in supply-chain management, manufacturing, and business operations. Previously, he led Global Manufacturing and Supply Chain for Teva Active Pharmaceutical Ingredients and held oversight responsibility for Teva’s biologics operations.
Prior to joining Teva in 2016, Mr. Hoey held senior leadership roles for global operations at Merck & Co., Inc., where he served in a variety of technical, supply chain, and contract manufacturing roles during the course of his 27 years there.
Mr. Hoey earned a bachelor’s of science in chemical engineering from Michigan State University. In addition, he holds an Executive Belt in Lean/Six Sigma and is also certified in change-execution methodology and behavior-based performance improvement.
Site Head, Procurement
Graham Degn is Site Head, Procurement, Teva Pharmaceuticals. He is based in Salt Lake City, Utah and is the Procurement Lead for Teva sites in Salt Lake City and Irvine, California. He has worked in the supply-chain /procurement side of pharmaceutical manufacturing for 13 years. During this time, he has been involved with numerous product launches, ranging in all forms of drug-delivery methods. He has a degree in business and has professional certifications from APICS and ASQ.
Vice President, Sales, Global Pharma
Arturo (Art) Castro is Vice President, Sales, Global Pharma at Amcor, where together with his team, he sets the global strategy and works to increase partnership with Amcor’s top global pharma customers.
He has been with Amcor for over 25 years with roles of increasing responsibility. Prior to his current role as Vice President Sales, Global Pharma, Mr. Castro was Vice President and General Manager for the Food & Pharmaceutical Americas business. For the last 20-plus years, Mr. Castro has been working on the 5P’s of marketing (product, place, price, promotion and packaging). He has been focused on helping customers grow and prosper globally through the application of novel packaging.
Prior to joining Amcor, Mr. Castro was a sergeant with the United States Marine Corps. He holds a bachelor’s of science in business, management and marketing. Originally from California, he is currently based in Zurich, Switzerland.
George Wu, PhD
Vice President and Presidential Fellow, Pharmaceutical Sciences
George Wu is Vice President and Presidential Fellow, Pharmaceutical Sciences, TESARO, an oncology-focused biopharmaceutical company. Dr. Wu has 29 years of experience and broad knowledge in pharmaceutical research and development covering new compound recommendation, early- and late-stage development, process transfer and validation, regulatory submission and approval, product launch, and lifecycle management at major pharmaceutical and biopharmaceutical companies.
Prior to joining TESARO, Dr. Wu worked for Merck & Co., Inc. and Schering-Plough, as a Distinguished Fellow—Senior Scientific Director, for 22 years. He has more than 70 publications and patents and has won various awards. Dr. Wu earned his PhD degree in chemistry under the direction of Professor Richard F. Heck at the University of Delaware and carried out his postdoctoral research with Professor Ei-ichi Negishi at Purdue University.
Heading to the Hyatt the evening before?
Join us June 25th from 8:00-10:00PM for our Pre-Program Welcome & Networking Reception at the Glass Woods Tavern on the first floor!
Schedule for June 26th:
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.